Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 3Vulvar Neoplasms 2Melanoma 2Liver Metastases 2Ulcer 1Skin Neoplasms 1Recurrence 1Rectal Neoplasms 1Pathologic Processes 1Pancreatic Neoplasms 1Neoplastic Processes 1Neoplasms 1Neoplasm Metastasis 1Melanoma, Cutaneous Malignant 1Liver Neoplasms 1Head and Neck Neoplasms 1Gynecological Cancers 1Desmoid Tumors 1Colorectal Neoplasms 1Breast Cancer Female 1

Interventions

Cisplatin 141Radiotherapy 115Cetuximab 95Docetaxel 69Radiotherapy, Intensity-Modulated 55Carboplatin 47pembrolizumab 46Surveys and Questionnaires 46Paclitaxel 41Fluorouracil 39Radiation 29Blood Specimen Collection 27Drug Therapy 26Erlotinib Hydrochloride 23Nivolumab 21Surgical Procedures, Operative 17Standard of Care 16Magnetic Resonance Spectroscopy 16Radiosurgery 14Pemetrexed 14Gemcitabine 14Everolimus 13Celecoxib 13durvalumab 12Low-Level Light Therapy 12Immunohistochemistry 12Cyclophosphamide 12Capecitabine 12Amifostine 12Chemoradiotherapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Head and Neck Neoplasms × Electrochemotherapy × Clear all
NCT02549742 2017-01-18

Electrochemotherapy on Head and Neck Cancer

Rigshospitalet, Denmark

Phase 2 Unknown
25 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡